131I-labelled chimeric monoclonal antibody Mov18 in ovarian cancer patients: a pilot study

I. van Zanten-Przybysz; C.F.M. Molthoff; G.W.M. Visser; RHM Verheijen; M.A.B.D. Plaizier; R. Pijpers; P. Kenemans; J.C. Roos

131I-labelled chimeric monoclonal antibody Mov18 in ovarian cancer patients: a pilot study

I. van Zanten-Przybysz, C.F.M. Molthoff, G.W.M. Visser, RHM Verheijen, M.A.B.D. Plaizier, R. Pijpers, P. Kenemans, J.C. Roos

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	179-188
Journal	Tumor Targeting
Volume	4
Publication status	Published - 1999

Cite this

@article{8ea68f853bb3422982b583ea606d2d45,

title = "131I-labelled chimeric monoclonal antibody Mov18 in ovarian cancer patients: a pilot study",

author = "{van Zanten-Przybysz}, I. and C.F.M. Molthoff and G.W.M. Visser and RHM Verheijen and M.A.B.D. Plaizier and R. Pijpers and P. Kenemans and J.C. Roos",

year = "1999",

language = "English",

volume = "4",

pages = "179--188",

}

TY - JOUR

T1 - 131I-labelled chimeric monoclonal antibody Mov18 in ovarian cancer patients: a pilot study

AU - van Zanten-Przybysz, I.

AU - Molthoff, C.F.M.

AU - Visser, G.W.M.

AU - Verheijen, RHM

AU - Plaizier, M.A.B.D.

AU - Pijpers, R.

AU - Kenemans, P.

AU - Roos, J.C.

PY - 1999

Y1 - 1999

M3 - Article

VL - 4

SP - 179

EP - 188

JO - Tumor Targeting

JF - Tumor Targeting

ER -